Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neurodegeneration and inflammation in MS: The eye teaches us about the storm.
B-cell targeted therapeutics in clinical development.
Multiple sclerosis: Monotherapy rules.
Inflammatory demyelinating diseases in children: an update.
Peripheral elevation of TNF-α leads to early synaptic abnormalities in the mouse somatosensory cortex in experimental autoimmune encephalomyelitis.
Analysis of polymorphisms in RIG-I-like receptor genes in German multiple sclerosis patients.
Neuroendocrine Responses to Transvascular Autonomic Modulation: A Modified Balloon Angioplasty in Multiple Sclerosis Patients.
Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors.
Polymorphisms of the CD24 Gene Are Associated with Risk of Multiple Sclerosis: A Meta-Analysis.
Multimodal Quantitative MR Imaging of the Thalamus in Multiple Sclerosis and Neuromyelitis Optica.
Oropharyngeal dysphagia in patients with multiple sclerosis: do the disease classification scales reflect dysphagia severity?
Multiple sclerosis and herpesvirus interaction.
Raltegravir with optimized background therapy for resistant HIV-1 infection.
Fingolimod Reduces Direct Medical Costs Compared to Natalizumab in Patients with Relapsing-Remitting Multiple Sclerosis in the Netherlands.
How type I interferons shape myeloid cell function in CNS autoimmunity.
Study protocol: To investigate effects of highly specialized rehabilitation for patients with multiple sclerosis a randomized controlled trial of a personalized, multidisciplinary intervention.
Serum antibodies to 25 myelin oligodendrocyte glycoprotein epitopes in multiple sclerosis and neuromyelitis optica: clinical value for diagnosis and disease activity.
Treatment Responsiveness in CIDP Patients with Diabetes Is Associated with Higher Degrees of Demyelination.
Multiple sclerosis registries in Europe - results of a systematic survey.
Latin American algorithm for treatment of relapsing-remitting multiple sclerosis using disease-modifying agents.
[Fingolimod compassionate use program : Case study on the concept of a therapy option for multiple sclerosis prior to marketing approval.]
Coexistence of peripheral myelin protein 22 and dystrophin mutations in a Chinese boy.
The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
Evaluation of retinal nerve fiber layer thickness measured by optical coherence tomography in Moroccan patients with multiple sclerosis.
Knee muscle strength in multiple sclerosis: relationship with gait characteristics.

Pages